MedPath

Trial of Computerized MET for Adolescent Substance Use

Phase 1
Withdrawn
Conditions
Drug Abuse
Alcohol Abuse
Nicotine Dependence
Interventions
Behavioral: MET
Behavioral: iMET
Registration Number
NCT01784653
Lead Sponsor
Boston Children's Hospital
Brief Summary

The purpose of this study is to test the effects of a computerized, self-directed Motivational Enhancement Therapy program for adolescent substance use (iMET), in comparison to clinician-delivered MET and Treatment As Usual (TAU), on treatment engagement and substance use. The investigators hypothesize that both iMET and MET will be more effective than TAU in engaging/retaining patients in treatment and in reducing substance use during a 12-month follow-up period. The investigators also hypothesize that Self-directed iMET will be as effective as the clinician-guided MET in increasing treatment engagement and abstinence during the 12-months follow-up period.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • completed initial visit at the treatment program;
  • be available to return for iMET/MET sessions (if assigned)
  • be available to complete all follow-up measurements
  • a past-12-month CRAFFT score >1
  • have used substances on >6 days (not including tobacco use) during the 90 days preceding their visit
Exclusion Criteria
  • unable to speak and understand English, or read English at a 5th grade reading level
  • youth deemed by the clinical team to require immediate hospitalization or referral to more intensive residential treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
METMETClinician-delivered Motivational Enhancement Therapy
iMETiMETParticipants will complete a self-guided computerized Motivational Enhancement Therapy
Primary Outcome Measures
NameTimeMethod
Treatment engagement12 months

We will compare the number of individual visits in the program, the number of group sessions completed, and the number of urine screens completed during a 12 month follow-up period by each participant in the three study arms.

Secondary Outcome Measures
NameTimeMethod
Days abstinentpast-90-days

We will calculate the past-90-days number of days abstinent from any substance use and from the primary substance and the number of weeks abstinent from any substance use.

Driving/Riding Riskpast-90-days

We will compare group trends in prevalence and frequency of past-90-days Driving while impaired or Riding with an impaired driver.

HIV Risk Behaviorpast-90-days

We will compare group trends in prevalence and frequency of past-90-days HIV Risk Behaviors.

Trial Locations

Locations (1)

Boston Children's Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath